Funding for this research was provided by:
National Institutes of Health (5P20GM103548-09)
Lush (2018 LUSH Prize (Young Investigator Award)
Article History
Received: 11 February 2020
Accepted: 22 April 2020
First Online: 1 May 2020
Ethics approval and consent to participate
: Tumor H&E images presented in Fig. InternalRef removed were generated using tumor samples provided by Sanford Biobank, Sioux Falls, SD. Informed consent was obtained from participants with approval from the Sanford Health Institutional Review Board and in accordance with the Declaration of Helsinki.
: Not applicable.
: Dr. de la Puente is the co-founder of Cellatrix LLC; however, there has been no contribution of the aforementioned entity to the current study. Other authors state no conflicts of interest.